During the past decade, Semmelweis Egyetem Neurológiai Klinika conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Semmelweis Egyetem Neurológiai Klinika" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Institut de Recherches Internationales Servier" with 2 trials sponsored, "Pierre Fabre Medicament" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Semmelweis Egyetem Neurológiai Klinika" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Semmelweis Egyetem Neurológiai Klinika" are "Alzheimer's Disease" (2 trials), "Ischemic Stroke" (2 trials), "Migraine" (2 trials), "Parkinson's Disease" (2 trials) and "Acute Vertigo" (1 trials). Many other conditions were trialed in "Semmelweis Egyetem Neurológiai Klinika" in a lesser frequency.

Most popular intervention types in "Semmelweis Egyetem Neurológiai Klinika" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ocrelizumab" (3 trials), "placebo" (2 trials), "F2695" (1 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Semmelweis Egyetem Neurológiai Klinika" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Semmelweis Egyetem Neurológiai Klinika". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Semmelweis Egyetem Neurológiai Klinika, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Semmelweis Egyetem Neurológiai Klinika, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".